No Recent Change in Prevalence of Diabetic Kidney Disease

This article originally appeared here.
Share this content:
No Recent Change in Prevalence of Diabetic Kidney Disease
No Recent Change in Prevalence of Diabetic Kidney Disease

WEDNESDAY, Aug. 10, 2016 (HealthDay News) -- From 1988 to 2014 there was no change in the overall prevalence of diabetic kidney disease, according to a study published in the Aug. 9 issue of the Journal of the American Medical Association.

Maryam Afkarian, M.D., Ph.D., from the University of Washington in Seattle, and colleagues characterized the clinical manifestations of kidney disease among U.S. adults with diabetes. Data were obtained from 6,251 adults aged 20 years and older with diabetes mellitus participating in the National Health and Nutrition Examination Surveys from 1988 through 2014.

The researchers observed no change over time in the prevalence of any diabetic kidney disease, defined as persistent albuminuria, persistent reduced estimated glomerular filtration rate (eGFR), or both (prevalence ratio, 0.95; 95 percent confidence interval [CI], 0.86 to 1.06, after adjustment for age, sex, and race/ethnicity). There was a decrease in the prevalence of albuminuria over time (adjusted prevalence ratio, 0.76; 95 percent CI, 0.65 to 0.89). The prevalence of reduced eGFR increased over time (adjusted prevalence ratio, 1.61; 95 percent CI, 1.33 to 1.95), and a similar pattern was seen for severely reduced eGFR (adjusted prevalence ratio, 2.86; 95 percent CI, 1.38 to 5.91).

"Among U.S. adults with diabetes from 1988 to 2014, the overall prevalence of diabetic kidney disease did not change significantly, whereas the prevalence of albuminuria declined and the prevalence of reduced eGFR increased," the authors write.

Several authors disclosed financial ties to the pharmaceutical and medical technology industries.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

SABCS: Artificial Intelligence May Aid Doctors in Breast ...

'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

Devices reduce blood flow to hair follicles during chemotherapy treatments

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

Women on aromatase inhibitors exhibit less elasticity in their blood vessels

is free, fast, and customized just for you!

Already a member?

Sign In Now »